Automated insulin delivery tech reaches new markets worldwide
Insulet has expanded its Omnipod 5 system to Australia, with upcoming launches planned for Belgium, Canada, and Switzerland—marking another step in the company’s international growth. This follows its rollout in five European countries earlier this year.
The tubeless, waterproof AID system, now integrated with the Dexcom G7 CGM, continues to lead as the top insulin pump for new users in Europe and remains the most prescribed AID system in the U.S.
Alongside its global expansion, Insulet also announced a $450 million offering in senior unsecured notes, signaling continued investment in scaling its reach and innovation in diabetes care.
Follow MEDWIRE.AI for global medtech expansion and innovation updates.
